The Philadelphia 76ers announced on Friday that top overall selection out of LSU, Ben Simmons will not play at all this season. "We've always anticipated there would be an opportunity for him to play, hopefully this season".
It's the latest body blow for a rebuilding franchise that was an National Basketball Association worst 10-72 last season and hasn't reached the postseason since the 2011-2012 campaign.
"But there was always the outside chance that it didn't happen because there wasn't complete and full healing".
LOST IN SPAAAAAACE! SpaceX aborts Space Station podule berthing
This NASA handout illustration image shows the SpaceX Dragon attached to the Space Station Harmony Module. However, things might get a bit crowded if the Dragon capsule is forced to abort again.
It is clear Simmons' recovery is behind schedule, though many felt there was no need to rush the promising rookie back into a season far from playoff expectations.
"Unfortunately, Ben is going to sit out".
Kraft Heinz Co (NASDAQ:KHC), Aetna Inc (NYSE:AET)
An alternative play: Kass says Kraft Heinz might play it safe and stick to its earlier script of acquiring another food company. The mean PT for this stock is at $39.38 while the max. level suggested by the brokerage firms is $51.00 and min.
"The good news is one day he'll put on a uniform". He initially was expected to miss three months after having surgery on October 4 to fix an acute Jones fracture in his foot.
The Victorian was Philadelphia's first No.1 overall pick since Allen Iverson in 1996 and all set to play point-forward. Embiid has been sidelined for almost a month with a knee injury, the 76ers traded forward Nerlens Noel in a move met with disapproval from many fans and reporters criticized Colangelo for a lack of transparency. That's a bit of a head-scratcher considering Bryan Colangelo said that the scan was clean in an official Sixers.com story on January 24.
Movers of Yesterday -Edison International (NYSE:EIX), Westlake Chemical Corporation (NYSE:WLK)
To assess that, I compare Westlake Chemical's cash and other liquid assets (current assets) against its overall debt. It focuses on offering ethylene co-products, including propylene, crude butadiene, pyrolysis gasoline, and hydrogen.